These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 7036337

  • 1. [Continuous subcutaneous insulin infusion brings about normal blood sugar in type I diabetes mellitus despite relaxing of diet instructions].
    Sonnenberg GE, Chantelau E, Altenähr H, Berger M, Berchtold P.
    Schweiz Med Wochenschr; 1982 Jan 16; 112(3):83-5. PubMed ID: 7036337
    [Abstract] [Full Text] [Related]

  • 2. Continuous subcutaneous insulin infusion in the treatment of juvenile-onset diabetes.
    Buysschaert M, Lejeune M, Lambert AE.
    Diabete Metab; 1981 Sep 16; 7(3):189-93. PubMed ID: 7319116
    [Abstract] [Full Text] [Related]

  • 3. Substitution of basal delivery of insulin by proinsulin in type I diabetic patients under CSII.
    Kerner W, Wallmüller G, Beischer W, Pfeiffer EF.
    Horm Metab Res Suppl; 1988 Sep 16; 18():74-7. PubMed ID: 3056816
    [Abstract] [Full Text] [Related]

  • 4. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I, Ortego J, Valencia I, García-Palacios MV, Aguilar-Diosdado M.
    Exp Clin Endocrinol Diabetes; 2009 Sep 16; 117(8):378-85. PubMed ID: 19629931
    [Abstract] [Full Text] [Related]

  • 5. Benefits of a bolus calculator in pre- and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII).
    Shashaj B, Busetto E, Sulli N.
    Diabet Med; 2008 Sep 16; 25(9):1036-42. PubMed ID: 18937673
    [Abstract] [Full Text] [Related]

  • 6. Diet and pump-treated diabetes: a long-term follow-up.
    Chantelau EA, Bockholt M, Lie KT, Broermann C, Sonnenberg GE, Berger M.
    Diabete Metab; 1983 Dec 16; 9(4):277-82. PubMed ID: 6667764
    [Abstract] [Full Text] [Related]

  • 7. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D, Crazzolara D, Maran A, Costa S, Dal Pos M, Girelli A, Lepore G, Aragona M, Iori E, Valentini U, Del Prato S, Tiengo A, Buhr A, Trevisan R, Baritussio A.
    Diabet Med; 2008 Mar 16; 25(3):326-32. PubMed ID: 18307459
    [Abstract] [Full Text] [Related]

  • 8. A comparison of premeal subcutaneous insulin infusion and injection in type I diabetic patients under continuous basal subcutaneous insulin delivery.
    Navascués I, Kerner W, Pfeiffer EF.
    Life Support Syst; 1985 Mar 16; 3(3):263-7. PubMed ID: 3900596
    [Abstract] [Full Text] [Related]

  • 9. Dietary practices of persons with diabetes during insulin pump therapy.
    Capper AF, Headen SW, Bergenstal RM.
    J Am Diet Assoc; 1985 Apr 16; 85(4):445-9. PubMed ID: 3980891
    [Abstract] [Full Text] [Related]

  • 10. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I, Weiss R, Yegorchikov Y, Bitton G, Nagar R, Pesach B.
    Clin Ther; 2009 May 16; 31(5):980-7. PubMed ID: 19539098
    [Abstract] [Full Text] [Related]

  • 11. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.
    Schütt M, Kern W, Krause U, Busch P, Dapp A, Grziwotz R, Mayer I, Rosenbauer J, Wagner C, Zimmermann A, Kerner W, Holl RW, DPV Initiative.
    Exp Clin Endocrinol Diabetes; 2006 Jul 16; 114(7):384-8. PubMed ID: 16915542
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Variation of insulin absorption during subcutaneous and peritoneal infusion in insulin-dependent diabetic patients with unsatisfactory long-term glycaemic response to continuous subcutaneous insulin infusion.
    Wredling R, Liu D, Lins PE, Adamson U.
    Diabete Metab; 1991 Jul 16; 17(5):456-9. PubMed ID: 1752346
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW.
    Clin Ther; 2007 Jul 16; 29 Suppl D():S135-44. PubMed ID: 18191065
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.